_id
691b083d3c536f8df231895d
Ticker
ABNX.PA
Name
Abionyx Pharma SA
Exchange
PA
Address
33 43 Ave Georges Pompidou Bldg D2, Balma, France, 31130
Country
France
Sector
Healthcare
Industry
Biotechnology
Currency
EUR
Website
https://abionyx.com
Description
ABIONYX Pharma SA, a biotech company, discovers and develops therapies for the treatment of renal and ophthalmological diseases. It develops CER-001, a negatively-charged lipoprotein particle that contains human recombinant apoA-I, the natural high-density lipoprotein (HDL) protein, and sphingomyelin and dipalmitoylphosphatidylglycerol natural phospholipids designed to mimic the structural and functional biological properties of pre-beta HDL for the treatment of post-acute coronary syndrome patients and familial primary hypoalphalipoproteinemia patients; CER-002, a peroxisome proliferator-activated receptor delta specific agonist for the treatment of cardiovascular and metabolic diseases; and CER-209, a drug candidate for the treatment of metabolic diseases in the liver, as well as atherosclerois and non-alcoholic steato-hepatitis (NASH). The company was formerly known as Cerenis Therapeutics Holding SA and changed its name to ABIONYX Pharma SA in August 2019. ABIONYX Pharma SA was founded in 2005 and is headquartered in Balma, France.
Last Close
3.53
Volume
124095
Current Price
3.735
Change
3.257790368271961
Last Updated
2025-12-30T12:32:23.199Z
Image
https://logo.clearbit.com/abionyx.com
Ipo Date
-
Market Cap
124531448
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.998
Sentiment Sources
1
Rating
4
Strong Buy
0
Buy
2
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-06-30
Revenue
2120000
Cost Of Revenue
1890000
Gross Profit
230000
Operating Expenses
2560000
Operating Income
-2330000
Interest Expense
58000
Pretax Income
-2300000
Net Income
-2300000
Eps
-0.06632622281619757
Dividends Per Share
-
Shares Outstanding
35278030
Income Tax Expense
-
EBITDA
-2277500
Operating Margin
-109.90566037735849
Total Other Income Expense Net
30000
Cash
3375000
Short Term Investments
-
Receivables
1687000
Inventories
208000
Total Current Assets
5449000
Property Plant Equipment
1928000
Total Assets
12978000
Payables
1264000
Short Term Debt
848000
Long Term Debt
-
Total Liabilities
7564000
Equity
5414000
Bs_currency_symbol
-
Depreciation
62500
Change In Working Capital
170000
Cash From Operations
-1700000
Capital Expenditures
162000
Cash From Investing
-160000
Cash From Financing
2000000
Net Change In Cash
140000
Cf_currency_symbol
-
PE
-
PB
23.922960609530843
ROE
-42.482452899889175
ROA
-17.722299275697335
FCF
-1862000
Fcf Percent
-0.8783018867924528
Piotroski FScore
1
Health Score
17
Deep Value Investing Score
1.5
Defensive Investing Score
6
Dividend Investing Score
1.5
Economic Moat Investing Score
3.3
Garp Investing Score
1.5
Growth Investing Score
1
Momentum Investing Score
4.5
Net Net Investing Score
2.5
Quality Investing Score
1.5
Value Investing Score
2
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
2120000
Quarters > 0 > income Statement > cost Of Revenue
1890000
Quarters > 0 > income Statement > gross Profit
230000
Quarters > 0 > income Statement > operating Expenses
2560000
Quarters > 0 > income Statement > operating Income
-2330000
Quarters > 0 > income Statement > interest Expense
58000
Quarters > 0 > income Statement > pretax Income
-2300000
Quarters > 0 > income Statement > net Income
-2300000
Quarters > 0 > income Statement > eps
-0.06632622281619757
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
34677084
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-2277500
Quarters > 0 > income Statement > operating Margin
-109.90566037735849
Quarters > 0 > income Statement > total Other Income Expense Net
30000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
3375000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
1687000
Quarters > 0 > balance Sheet > inventories
208000
Quarters > 0 > balance Sheet > total Current Assets
5449000
Quarters > 0 > balance Sheet > property Plant Equipment
1928000
Quarters > 0 > balance Sheet > total Assets
12978000
Quarters > 0 > balance Sheet > payables
1264000
Quarters > 0 > balance Sheet > short Term Debt
848000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
7564000
Quarters > 0 > balance Sheet > equity
5414000
Quarters > 0 > balance Sheet > currency_symbol
-
Quarters > 0 > cash Flow > net Income
-2300000
Quarters > 0 > cash Flow > depreciation
62500
Quarters > 0 > cash Flow > change In Working Capital
170000
Quarters > 0 > cash Flow > cash From Operations
-1700000
Quarters > 0 > cash Flow > capital Expenditures
162000
Quarters > 0 > cash Flow > cash From Investing
-160000
Quarters > 0 > cash Flow > cash From Financing
2000000
Quarters > 0 > cash Flow > net Change In Cash
140000
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.06632622281619757
Quarters > 0 > ratios > PB
23.922960609530843
Quarters > 0 > ratios > ROE
-42.482452899889175
Quarters > 0 > ratios > ROA
-17.722299275697335
Quarters > 0 > ratios > FCF
-1862000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-0.8783018867924528
Quarters > 0 > health Score
17
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
2256000
Quarters > 1 > income Statement > cost Of Revenue
1659000
Quarters > 1 > income Statement > gross Profit
597000
Quarters > 1 > income Statement > operating Expenses
3433000
Quarters > 1 > income Statement > operating Income
-2341000
Quarters > 1 > income Statement > interest Expense
19000
Quarters > 1 > income Statement > pretax Income
-2293000
Quarters > 1 > income Statement > net Income
-2293000
Quarters > 1 > income Statement > eps
-0.06612452057559766
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
34677000
Quarters > 1 > income Statement > income Tax Expense
-636000
Quarters > 1 > income Statement > EBITDA
2051000
Quarters > 1 > income Statement > operating Margin
-103.7677304964539
Quarters > 1 > income Statement > total Other Income Expense Net
48000
Quarters > 1 > income Statement > currency_symbol
EUR
Quarters > 1 > balance Sheet > cash
3235000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
2295000
Quarters > 1 > balance Sheet > inventories
211000
Quarters > 1 > balance Sheet > total Current Assets
5859000
Quarters > 1 > balance Sheet > property Plant Equipment
1984000
Quarters > 1 > balance Sheet > total Assets
13450000
Quarters > 1 > balance Sheet > payables
1629000
Quarters > 1 > balance Sheet > short Term Debt
1184000
Quarters > 1 > balance Sheet > long Term Debt
611000
Quarters > 1 > balance Sheet > total Liabilities
6026000
Quarters > 1 > balance Sheet > equity
7424000
Quarters > 1 > balance Sheet > currency_symbol
EUR
Quarters > 1 > cash Flow > net Income
-2293000
Quarters > 1 > cash Flow > depreciation
-73000
Quarters > 1 > cash Flow > change In Working Capital
80000
Quarters > 1 > cash Flow > cash From Operations
-1760000
Quarters > 1 > cash Flow > capital Expenditures
23000
Quarters > 1 > cash Flow > cash From Investing
-49000
Quarters > 1 > cash Flow > cash From Financing
-260000
Quarters > 1 > cash Flow > net Change In Cash
-2069000
Quarters > 1 > cash Flow > currency_symbol
EUR
Quarters > 1 > ratios > PE
-0.06612452057559766
Quarters > 1 > ratios > PB
17.445931438577585
Quarters > 1 > ratios > ROE
-30.886314655172413
Quarters > 1 > ratios > ROA
-17.04832713754647
Quarters > 1 > ratios > FCF
-1783000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-0.7903368794326241
Quarters > 1 > health Score
23
Quarters > 2 > quarter
2024-06-30
Quarters > 2 > income Statement > revenue
2344000
Quarters > 2 > income Statement > cost Of Revenue
2041000
Quarters > 2 > income Statement > gross Profit
303000
Quarters > 2 > income Statement > operating Expenses
2862000
Quarters > 2 > income Statement > operating Income
-2587000
Quarters > 2 > income Statement > interest Expense
42000
Quarters > 2 > income Statement > pretax Income
-2538000
Quarters > 2 > income Statement > net Income
-2088000
Quarters > 2 > income Statement > eps
-0.06483465300419189
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
32205000
Quarters > 2 > income Statement > income Tax Expense
-450000
Quarters > 2 > income Statement > EBITDA
-2291000
Quarters > 2 > income Statement > operating Margin
-110.36689419795222
Quarters > 2 > income Statement > total Other Income Expense Net
49000
Quarters > 2 > income Statement > currency_symbol
EUR
Quarters > 2 > balance Sheet > cash
5304000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
1872000
Quarters > 2 > balance Sheet > inventories
201000
Quarters > 2 > balance Sheet > total Current Assets
7548000
Quarters > 2 > balance Sheet > property Plant Equipment
2184000
Quarters > 2 > balance Sheet > total Assets
15460000
Quarters > 2 > balance Sheet > payables
1151000
Quarters > 2 > balance Sheet > short Term Debt
843000
Quarters > 2 > balance Sheet > long Term Debt
857000
Quarters > 2 > balance Sheet > total Liabilities
6012000
Quarters > 2 > balance Sheet > equity
9448000
Quarters > 2 > balance Sheet > currency_symbol
EUR
Quarters > 2 > cash Flow > net Income
-2088000
Quarters > 2 > cash Flow > depreciation
205000
Quarters > 2 > cash Flow > change In Working Capital
-80000
Quarters > 2 > cash Flow > cash From Operations
-1874000
Quarters > 2 > cash Flow > capital Expenditures
23000
Quarters > 2 > cash Flow > cash From Investing
-27000
Quarters > 2 > cash Flow > cash From Financing
3104000
Quarters > 2 > cash Flow > net Change In Cash
1200000
Quarters > 2 > cash Flow > currency_symbol
EUR
Quarters > 2 > ratios > PE
-0.06483465300419189
Quarters > 2 > ratios > PB
12.731337320067738
Quarters > 2 > ratios > ROE
-22.09991532599492
Quarters > 2 > ratios > ROA
-13.50582147477361
Quarters > 2 > ratios > FCF
-1897000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-0.8093003412969283
Quarters > 2 > health Score
23
Quarters > 3 > quarter
2023-12-31
Quarters > 3 > income Statement > revenue
2512000
Quarters > 3 > income Statement > cost Of Revenue
1883000
Quarters > 3 > income Statement > gross Profit
629000
Quarters > 3 > income Statement > operating Expenses
1813000
Quarters > 3 > income Statement > operating Income
-1184000
Quarters > 3 > income Statement > interest Expense
138000
Quarters > 3 > income Statement > pretax Income
-1270000
Quarters > 3 > income Statement > net Income
-1270000
Quarters > 3 > income Statement > eps
-0.04074430542188001
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
31170000
Quarters > 3 > income Statement > income Tax Expense
-1388000
Quarters > 3 > income Statement > EBITDA
-1137000
Quarters > 3 > income Statement > operating Margin
-47.13375796178344
Quarters > 3 > income Statement > total Other Income Expense Net
-86000
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
4104000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
919000
Quarters > 3 > balance Sheet > inventories
221000
Quarters > 3 > balance Sheet > total Current Assets
6886000
Quarters > 3 > balance Sheet > property Plant Equipment
2215000
Quarters > 3 > balance Sheet > total Assets
14710000
Quarters > 3 > balance Sheet > payables
1439000
Quarters > 3 > balance Sheet > short Term Debt
815000
Quarters > 3 > balance Sheet > long Term Debt
1101000
Quarters > 3 > balance Sheet > total Liabilities
6912000
Quarters > 3 > balance Sheet > equity
7922000
Quarters > 3 > balance Sheet > currency_symbol
EUR
Quarters > 3 > cash Flow > net Income
-1270000
Quarters > 3 > cash Flow > depreciation
66000
Quarters > 3 > cash Flow > change In Working Capital
754000
Quarters > 3 > cash Flow > cash From Operations
-1159000
Quarters > 3 > cash Flow > capital Expenditures
36000
Quarters > 3 > cash Flow > cash From Investing
-59000
Quarters > 3 > cash Flow > cash From Financing
3392000
Quarters > 3 > cash Flow > net Change In Cash
2170000
Quarters > 3 > cash Flow > currency_symbol
EUR
Quarters > 3 > ratios > PE
-0.04074430542188001
Quarters > 3 > ratios > PB
14.695777581418835
Quarters > 3 > ratios > ROE
-16.03130522595304
Quarters > 3 > ratios > ROA
-8.633582596872875
Quarters > 3 > ratios > FCF
-1195000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-0.47571656050955413
Quarters > 3 > health Score
23
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
4600000
Annuals > 0 > income Statement > cost Of Revenue
3700000
Annuals > 0 > income Statement > gross Profit
844000
Annuals > 0 > income Statement > operating Expenses
5309000
Annuals > 0 > income Statement > operating Income
-5572000
Annuals > 0 > income Statement > interest Expense
61000
Annuals > 0 > income Statement > pretax Income
-5467000
Annuals > 0 > income Statement > net Income
-4400000
Annuals > 0 > income Statement > eps
-0.13058317257753377
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
33695000
Annuals > 0 > income Statement > income Tax Expense
-1067000
Annuals > 0 > income Statement > EBITDA
-4928000
Annuals > 0 > income Statement > operating Margin
-121.1304347826087
Annuals > 0 > income Statement > total Other Income Expense Net
84000
Annuals > 0 > income Statement > currency_symbol
EUR
Annuals > 0 > balance Sheet > cash
3235000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
2295000
Annuals > 0 > balance Sheet > inventories
211000
Annuals > 0 > balance Sheet > total Current Assets
5859000
Annuals > 0 > balance Sheet > property Plant Equipment
1984000
Annuals > 0 > balance Sheet > total Assets
13450000
Annuals > 0 > balance Sheet > payables
1629000
Annuals > 0 > balance Sheet > short Term Debt
1184000
Annuals > 0 > balance Sheet > long Term Debt
611000
Annuals > 0 > balance Sheet > total Liabilities
6026000
Annuals > 0 > balance Sheet > equity
7424000
Annuals > 0 > balance Sheet > currency_symbol
EUR
Annuals > 0 > cash Flow > net Income
-4381000
Annuals > 0 > cash Flow > depreciation
135000
Annuals > 0 > cash Flow > change In Working Capital
-28000
Annuals > 0 > cash Flow > cash From Operations
-3600000
Annuals > 0 > cash Flow > capital Expenditures
76000
Annuals > 0 > cash Flow > cash From Investing
-100000
Annuals > 0 > cash Flow > cash From Financing
2800000
Annuals > 0 > cash Flow > net Change In Cash
-902000
Annuals > 0 > cash Flow > currency_symbol
EUR
Annuals > 0 > ratios > PE
-0.13058317257753377
Annuals > 0 > ratios > PB
16.56610317887931
Annuals > 0 > ratios > ROE
-59.26724137931034
Annuals > 0 > ratios > ROA
-32.71375464684015
Annuals > 0 > ratios > FCF
-3676000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-0.7991304347826087
Annuals > 0 > health Score
22
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
4640000
Annuals > 1 > income Statement > cost Of Revenue
4022000
Annuals > 1 > income Statement > gross Profit
618000
Annuals > 1 > income Statement > operating Expenses
4030000
Annuals > 1 > income Statement > operating Income
-3412000
Annuals > 1 > income Statement > interest Expense
19000
Annuals > 1 > income Statement > pretax Income
-3518000
Annuals > 1 > income Statement > net Income
-3518000
Annuals > 1 > income Statement > eps
-0.11986371379897785
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
29350000
Annuals > 1 > income Statement > income Tax Expense
-1384000
Annuals > 1 > income Statement > EBITDA
-4844000
Annuals > 1 > income Statement > operating Margin
-73.53448275862068
Annuals > 1 > income Statement > total Other Income Expense Net
-106000
Annuals > 1 > income Statement > currency_symbol
EUR
Annuals > 1 > balance Sheet > cash
4104000
Annuals > 1 > balance Sheet > short Term Investments
50000
Annuals > 1 > balance Sheet > receivables
2495000
Annuals > 1 > balance Sheet > inventories
221000
Annuals > 1 > balance Sheet > total Current Assets
6886000
Annuals > 1 > balance Sheet > property Plant Equipment
2215000
Annuals > 1 > balance Sheet > total Assets
14834000
Annuals > 1 > balance Sheet > payables
1439000
Annuals > 1 > balance Sheet > short Term Debt
815000
Annuals > 1 > balance Sheet > long Term Debt
1101000
Annuals > 1 > balance Sheet > total Liabilities
6912000
Annuals > 1 > balance Sheet > equity
7922000
Annuals > 1 > balance Sheet > currency_symbol
EUR
Annuals > 1 > cash Flow > net Income
-3518000
Annuals > 1 > cash Flow > depreciation
153000
Annuals > 1 > cash Flow > change In Working Capital
538000
Annuals > 1 > cash Flow > cash From Operations
-3698000
Annuals > 1 > cash Flow > capital Expenditures
130000
Annuals > 1 > cash Flow > cash From Investing
-130000
Annuals > 1 > cash Flow > cash From Financing
3886000
Annuals > 1 > cash Flow > net Change In Cash
58000
Annuals > 1 > cash Flow > currency_symbol
EUR
Annuals > 1 > ratios > PE
-0.11986371379897785
Annuals > 1 > ratios > PB
13.522784650340823
Annuals > 1 > ratios > ROE
-44.407977783388034
Annuals > 1 > ratios > ROA
-23.71578805446946
Annuals > 1 > ratios > FCF
-3828000
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-0.825
Annuals > 1 > health Score
23
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
5252000
Annuals > 2 > income Statement > cost Of Revenue
4616000
Annuals > 2 > income Statement > gross Profit
636000
Annuals > 2 > income Statement > operating Expenses
4745000
Annuals > 2 > income Statement > operating Income
-4109000
Annuals > 2 > income Statement > interest Expense
240000
Annuals > 2 > income Statement > pretax Income
-4206000
Annuals > 2 > income Statement > net Income
-4206000
Annuals > 2 > income Statement > eps
-0.15039153287803483
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
27967000
Annuals > 2 > income Statement > income Tax Expense
-1456000
Annuals > 2 > income Statement > EBITDA
-4010000
Annuals > 2 > income Statement > operating Margin
-78.23686214775324
Annuals > 2 > income Statement > total Other Income Expense Net
-97000
Annuals > 2 > income Statement > currency_symbol
EUR
Annuals > 2 > balance Sheet > cash
4046000
Annuals > 2 > balance Sheet > short Term Investments
-41000
Annuals > 2 > balance Sheet > receivables
1297000
Annuals > 2 > balance Sheet > inventories
147000
Annuals > 2 > balance Sheet > total Current Assets
7572000
Annuals > 2 > balance Sheet > property Plant Equipment
2559000
Annuals > 2 > balance Sheet > total Assets
15823000
Annuals > 2 > balance Sheet > payables
1853000
Annuals > 2 > balance Sheet > short Term Debt
870000
Annuals > 2 > balance Sheet > long Term Debt
1415000
Annuals > 2 > balance Sheet > total Liabilities
8654000
Annuals > 2 > balance Sheet > equity
7169000
Annuals > 2 > balance Sheet > currency_symbol
EUR
Annuals > 2 > cash Flow > net Income
-4206000
Annuals > 2 > cash Flow > depreciation
135000
Annuals > 2 > cash Flow > change In Working Capital
97000
Annuals > 2 > cash Flow > cash From Operations
-3359000
Annuals > 2 > cash Flow > capital Expenditures
175000
Annuals > 2 > cash Flow > cash From Investing
-175000
Annuals > 2 > cash Flow > cash From Financing
-194000
Annuals > 2 > cash Flow > net Change In Cash
-3728000
Annuals > 2 > cash Flow > currency_symbol
EUR
Annuals > 2 > ratios > PE
-0.15039153287803483
Annuals > 2 > ratios > PB
14.2390221788255
Annuals > 2 > ratios > ROE
-58.6692704700795
Annuals > 2 > ratios > ROA
-26.581558490804525
Annuals > 2 > ratios > FCF
-3534000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-0.6728865194211728
Annuals > 2 > health Score
16
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
675000
Annuals > 3 > income Statement > cost Of Revenue
416000
Annuals > 3 > income Statement > gross Profit
259000
Annuals > 3 > income Statement > operating Expenses
6211000
Annuals > 3 > income Statement > operating Income
-5952000
Annuals > 3 > income Statement > interest Expense
124000
Annuals > 3 > income Statement > pretax Income
-5822000
Annuals > 3 > income Statement > net Income
-5822000
Annuals > 3 > income Statement > eps
-0.2340032154340836
Annuals > 3 > income Statement > dividends Per Share
3972000
Annuals > 3 > income Statement > shares Outstanding
24880000
Annuals > 3 > income Statement > income Tax Expense
8000
Annuals > 3 > income Statement > EBITDA
-7418000
Annuals > 3 > income Statement > operating Margin
-881.7777777777778
Annuals > 3 > income Statement > total Other Income Expense Net
130000
Annuals > 3 > income Statement > currency_symbol
EUR
Annuals > 3 > balance Sheet > cash
7935000
Annuals > 3 > balance Sheet > short Term Investments
-31000
Annuals > 3 > balance Sheet > receivables
1569000
Annuals > 3 > balance Sheet > inventories
177000
Annuals > 3 > balance Sheet > total Current Assets
13011000
Annuals > 3 > balance Sheet > property Plant Equipment
3066000
Annuals > 3 > balance Sheet > total Assets
21832000
Annuals > 3 > balance Sheet > payables
2705000
Annuals > 3 > balance Sheet > short Term Debt
1054000
Annuals > 3 > balance Sheet > long Term Debt
1653000
Annuals > 3 > balance Sheet > total Liabilities
11155000
Annuals > 3 > balance Sheet > equity
10677000
Annuals > 3 > balance Sheet > currency_symbol
EUR
Annuals > 3 > cash Flow > net Income
-5822000
Annuals > 3 > cash Flow > depreciation
119000
Annuals > 3 > cash Flow > change In Working Capital
-1744000
Annuals > 3 > cash Flow > cash From Operations
-6692000
Annuals > 3 > cash Flow > capital Expenditures
166000
Annuals > 3 > cash Flow > cash From Investing
1338000
Annuals > 3 > cash Flow > cash From Financing
3972000
Annuals > 3 > cash Flow > net Change In Cash
-1382000
Annuals > 3 > cash Flow > currency_symbol
EUR
Annuals > 3 > ratios > PE
-0.2340032154340836
Annuals > 3 > ratios > PB
8.505385407886111
Annuals > 3 > ratios > ROE
-54.5284255877119
Annuals > 3 > ratios > ROA
-26.66727739098571
Annuals > 3 > ratios > FCF
-6858000
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-10.16
Annuals > 3 > health Score
17
Valuation > metrics > PE
-0.06632622281619757
Valuation > metrics > PB
23.922960609530843
Valuation > final Score
20
Valuation > verdict
697.4% Overvalued
Profitability > metrics > ROE
-42.482452899889175
Profitability > metrics > ROA
-42.209579739401725
Profitability > metrics > Net Margin
-1.0849056603773586
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
1.3971185814554858
Risk > metrics > Interest Coverage
-40.172413793103445
Risk > final Score
-131
Risk > verdict
High
Liquidity > metrics > Current Ratio
2.5800189393939394
Liquidity > metrics > Quick Ratio
2.481534090909091
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
20
Prev Valuations > 1
20
Prev Valuations > 2
20
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-445
Prev Risks > 1
-198
Prev Risks > 2
14
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T23:08:25.643Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-04
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-11-25
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
0
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-09-25
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.03
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-05-28
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
0
Earnings History > 3 > eps Estimate
0
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2025-03-17
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
-0.07
Earnings History > 4 > eps Estimate
0
Earnings History > 4 > eps Difference
-0.07
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-11-14
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
-
Earnings History > 5 > eps Actual
0
Earnings History > 5 > eps Estimate
0
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-09-26
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
-
Earnings History > 6 > eps Actual
0
Earnings History > 6 > eps Estimate
0
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2024-03-31
Earnings History > 7 > report Date
2024-05-16
Earnings History > 7 > date
2024-03-31
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
-
Earnings History > 7 > eps Actual
0
Earnings History > 7 > eps Estimate
0
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2023-12-31
Earnings History > 8 > report Date
2024-03-11
Earnings History > 8 > date
2023-12-31
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
EUR
Earnings History > 8 > eps Actual
0
Earnings History > 8 > eps Estimate
0
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2023-09-30
Earnings History > 9 > report Date
2023-11-21
Earnings History > 9 > date
2023-09-30
Earnings History > 9 > before After Market
BeforeMarket
Earnings History > 9 > currency
EUR
Earnings History > 9 > eps Actual
0
Earnings History > 9 > eps Estimate
0
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2023-06-30
Earnings History > 10 > report Date
2023-08-17
Earnings History > 10 > date
2023-06-30
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
EUR
Earnings History > 10 > eps Actual
0
Earnings History > 10 > eps Estimate
0
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2023-03-31
Earnings History > 11 > report Date
2023-05-17
Earnings History > 11 > date
2023-03-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
EUR
Earnings History > 11 > eps Actual
0
Earnings History > 11 > eps Estimate
0
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2022-12-31
Earnings History > 12 > report Date
2023-03-29
Earnings History > 12 > date
2022-12-31
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
EUR
Earnings History > 12 > eps Actual
-0.06
Earnings History > 12 > eps Estimate
0
Earnings History > 12 > eps Difference
-0.06
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2022-09-30
Earnings History > 13 > report Date
2022-11-17
Earnings History > 13 > date
2022-09-30
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
EUR
Earnings History > 13 > eps Actual
0
Earnings History > 13 > eps Estimate
0
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2022-06-30
Earnings History > 14 > report Date
2022-08-18
Earnings History > 14 > date
2022-06-30
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
EUR
Earnings History > 14 > eps Actual
-0.09
Earnings History > 14 > eps Estimate
-
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2022-03-31
Earnings History > 15 > report Date
2022-04-29
Earnings History > 15 > date
2022-03-31
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
EUR
Earnings History > 15 > eps Actual
-0.13
Earnings History > 15 > eps Estimate
0
Earnings History > 15 > eps Difference
-0.13
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-11-04
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
AfterMarket
Earnings History > 16 > currency
EUR
Earnings History > 16 > eps Actual
0
Earnings History > 16 > eps Estimate
0
Earnings History > 16 > eps Difference
0
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-08-05
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
AfterMarket
Earnings History > 17 > currency
EUR
Earnings History > 17 > eps Actual
-0.1
Earnings History > 17 > eps Estimate
-0.1
Earnings History > 17 > eps Difference
0
Earnings History > 17 > surprise Percent
0
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-05-06
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
AfterMarket
Earnings History > 18 > currency
EUR
Earnings History > 18 > eps Actual
0
Earnings History > 18 > eps Estimate
0
Earnings History > 18 > eps Difference
0
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2021-02-25
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
AfterMarket
Earnings History > 19 > currency
EUR
Earnings History > 19 > eps Actual
-0.04
Earnings History > 19 > eps Estimate
0
Earnings History > 19 > eps Difference
-0.04
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2020-09-30
Earnings History > 20 > report Date
2020-10-22
Earnings History > 20 > date
2020-09-30
Earnings History > 20 > before After Market
AfterMarket
Earnings History > 20 > currency
EUR
Earnings History > 20 > eps Actual
0
Earnings History > 20 > eps Estimate
0
Earnings History > 20 > eps Difference
0
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2020-06-30
Earnings History > 21 > report Date
2020-09-10
Earnings History > 21 > date
2020-06-30
Earnings History > 21 > before After Market
AfterMarket
Earnings History > 21 > currency
EUR
Earnings History > 21 > eps Actual
-0.04
Earnings History > 21 > eps Estimate
0
Earnings History > 21 > eps Difference
-0.04
Earnings History > 21 > surprise Percent
-
Earnings History > 22 > period
2020-03-31
Earnings History > 22 > report Date
2020-04-23
Earnings History > 22 > date
2020-03-31
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
EUR
Earnings History > 22 > eps Actual
0
Earnings History > 22 > eps Estimate
0
Earnings History > 22 > eps Difference
0
Earnings History > 22 > surprise Percent
-
Earnings History > 23 > period
2019-12-31
Earnings History > 23 > report Date
2020-03-10
Earnings History > 23 > date
2019-12-31
Earnings History > 23 > before After Market
AfterMarket
Earnings History > 23 > currency
EUR
Earnings History > 23 > eps Actual
-0.05
Earnings History > 23 > eps Estimate
0
Earnings History > 23 > eps Difference
-0.05
Earnings History > 23 > surprise Percent
-
Earnings History > 24 > period
2019-09-30
Earnings History > 24 > report Date
2019-10-24
Earnings History > 24 > date
2019-09-30
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
EUR
Earnings History > 24 > eps Actual
0
Earnings History > 24 > eps Estimate
0
Earnings History > 24 > eps Difference
0
Earnings History > 24 > surprise Percent
-
Earnings History > 25 > period
2019-06-30
Earnings History > 25 > report Date
2019-09-06
Earnings History > 25 > date
2019-06-30
Earnings History > 25 > before After Market
AfterMarket
Earnings History > 25 > currency
EUR
Earnings History > 25 > eps Actual
0.15
Earnings History > 25 > eps Estimate
0
Earnings History > 25 > eps Difference
0.15
Earnings History > 25 > surprise Percent
-
Earnings History > 26 > period
2019-03-31
Earnings History > 26 > report Date
2019-04-29
Earnings History > 26 > date
2019-03-31
Earnings History > 26 > before After Market
AfterMarket
Earnings History > 26 > currency
EUR
Earnings History > 26 > eps Actual
0
Earnings History > 26 > eps Estimate
0
Earnings History > 26 > eps Difference
0
Earnings History > 26 > surprise Percent
-
Earnings History > 27 > period
2018-12-31
Earnings History > 27 > report Date
2019-01-24
Earnings History > 27 > date
2018-12-31
Earnings History > 27 > before After Market
AfterMarket
Earnings History > 27 > currency
EUR
Earnings History > 27 > eps Actual
-0.15
Earnings History > 27 > eps Estimate
0
Earnings History > 27 > eps Difference
-0.15
Earnings History > 27 > surprise Percent
-
Earnings History > 28 > period
2018-09-30
Earnings History > 28 > report Date
2018-11-28
Earnings History > 28 > date
2018-09-30
Earnings History > 28 > before After Market
-
Earnings History > 28 > currency
EUR
Earnings History > 28 > eps Actual
0
Earnings History > 28 > eps Estimate
0
Earnings History > 28 > eps Difference
0
Earnings History > 28 > surprise Percent
-
Earnings History > 29 > period
2018-06-30
Earnings History > 29 > report Date
2018-09-10
Earnings History > 29 > date
2018-06-30
Earnings History > 29 > before After Market
BeforeMarket
Earnings History > 29 > currency
EUR
Earnings History > 29 > eps Actual
-0.19
Earnings History > 29 > eps Estimate
0
Earnings History > 29 > eps Difference
-0.19
Earnings History > 29 > surprise Percent
-
Earnings History > 30 > period
2018-03-31
Earnings History > 30 > report Date
2018-04-19
Earnings History > 30 > date
2018-03-31
Earnings History > 30 > before After Market
BeforeMarket
Earnings History > 30 > currency
EUR
Earnings History > 30 > eps Actual
0
Earnings History > 30 > eps Estimate
0
Earnings History > 30 > eps Difference
0
Earnings History > 30 > surprise Percent
-
Earnings History > 31 > period
2017-12-31
Earnings History > 31 > report Date
2018-02-02
Earnings History > 31 > date
2017-12-31
Earnings History > 31 > before After Market
AfterMarket
Earnings History > 31 > currency
EUR
Earnings History > 31 > eps Actual
-0.23
Earnings History > 31 > eps Estimate
0
Earnings History > 31 > eps Difference
-0.23
Earnings History > 31 > surprise Percent
-
Earnings History > 32 > period
2017-06-30
Earnings History > 32 > report Date
2017-09-12
Earnings History > 32 > date
2017-06-30
Earnings History > 32 > before After Market
AfterMarket
Earnings History > 32 > currency
EUR
Earnings History > 32 > eps Actual
-0.04
Earnings History > 32 > eps Estimate
0
Earnings History > 32 > eps Difference
-0.04
Earnings History > 32 > surprise Percent
-
Earnings History > 33 > period
2016-09-30
Earnings History > 33 > report Date
2016-11-07
Earnings History > 33 > date
2016-09-30
Earnings History > 33 > before After Market
BeforeMarket
Earnings History > 33 > currency
EUR
Earnings History > 33 > eps Actual
0
Earnings History > 33 > eps Estimate
0
Earnings History > 33 > eps Difference
0
Earnings History > 33 > surprise Percent
-
ABIONYX Pharma SA, a biotech company, discovers and develops therapies for the treatment of renal and ophthalmological diseases. It develops CER-001, a negatively-charged lipoprotein particle that contains human recombinant apoA-I, the natural high-density lipoprotein (HDL) protein, and sphingomyelin and dipalmitoylphosphatidylglycerol natural phospholipids designed to mimic the structural and functional biological properties of pre-beta HDL for the treatment of post-acute coronary syndrome patients and familial primary hypoalphalipoproteinemia patients; CER-002, a peroxisome proliferator-activated receptor delta specific agonist for the treatment of cardiovascular and metabolic diseases; and CER-209, a drug candidate for the treatment of metabolic diseases in the liver, as well as atherosclerois and non-alcoholic steato-hepatitis (NASH). The company was formerly known as Cerenis Therapeutics Holding SA and changed its name to ABIONYX Pharma SA in August 2019. ABIONYX Pharma SA was founded in 2005 and is headquartered in Balma, France.
Stock Price
€0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A3 European Penny Stocks With Market Caps Over €30M To Watch Yahoo Finance
Read more →ABIONYX Pharma SA (EPA:ABNX) surges 32%; retail investors who own 55% shares profited along with insiders simplywall.st
Read more →Showing 2 of 4
(Last Updated 2025-06-30)
Rating:
BUY
$
Analyst Picks
Strong Buy
0
Buy
2
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Abionyx Pharma SA
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
—
Date
2025-09-30
EPS Actual
0
EPS Estimate
0
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
€ 0
Cost Of Revenue
€ 0
Gross Profit
€ 0
Operating Expenses
€ 0
Operating Income
€ 0
Interest Expense
€ 0
Pretax Income
€ 0
Net Income
€ 0
Income Tax Expense
€ 0
EBITDA
€ 0
Total Other Income Expense Net
€ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
€ 0
Short Term Investments
€ 0
Receivables
€ 0
Inventories
€ 0
Total Current Assets
€ 0
Property Plant Equipment
€ 0
Total Assets
€ 0
Payables
€ 0
Short Term Debt
€ 0
Long Term Debt
€ 0
Total Liabilities
€ 0
Equity
€ 0
(Last Updated 2025-06-30)
Net Income
€ 0
Depreciation
€ 0
Change In Working Capital
€ 0
Cash From Operations
€ 0
Capital Expenditures
€ 0
Cash From Investing
€ 0
Cash From Financing
€ 0
Net Change In Cash
€ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.